Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Regular Article

Major Depressive Disorder with Anger: A Bipolar Spectrum Disorder?

Benazzi F.

Author affiliations

Outpatient Psychiatry Center, University of California, San Diego, Calif., USA; Collaborating Center, Ravenna and Forlì, and Department of Psychiatry, National Health Service, Forlì, and Department of Psychology, University of Bologna, Bologna, Italy

Related Articles for ""

Psychother Psychosom 2003;72:300–306

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Regular Article

Published online: October 09, 2003
Issue release date: November – December

Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 2

ISSN: 0033-3190 (Print)
eISSN: 1423-0348 (Online)

For additional information: https://www.karger.com/PPS

Abstract

Background: Depression with anger may be more common in bipolar disorders. The aim of the study was to assess whether major depressive disorder (MDD) with anger could be included in the bipolar spectrum, by comparing it to MDD without anger and to bipolar II disorder. Methods: Consecutive outpatients (281 bipolar II disorder and 202 MDD) presenting for major depressive episode (MDE) treatment were interviewed with the DSM-IV structured clinical interview. Clinical variables used to support the inclusion of MDD with anger in the bipolar spectrum were age of onset, many MDE recurrences, atypical features of depression, depressive mixed state (an MDE plus some concurrent hypomanic symptoms), and bipolar family history. Results: Frequency of MDE with anger was 50.5% [61.2% in bipolar II, and 35.6% in MDD (z = 5.5, p = 0.0000, 95% CI 16.8–43.3%)]. Logistic regression of MDE with anger (dependent variable) versus bipolar variables showed that MDE with anger was significantly associated with all bipolar variables, apart from recurrences. MDD with anger, compared with MDD without anger, had significantly lower age of onset, more marked depressive mixed state, a bipolar family history with more cases, but comparable atypical features and Global Assessment of Functioning scores. MDD with anger, compared with bipolar II disorder, had significantly higher age of onset, less atypical features, and a bipolar family history with less cases. Conclusions: MDE with anger was common in outpatients (more in bipolar II disorder). MDD with anger may be midway between MDD without anger and bipolar II disorder, and might be included into the bipolar spectrum. However, MDD with anger does not appear to be associated with the often reported negative response to monotherapy with antidepressants.

© 2003 S. Karger AG, Basel


References

  1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Text Revision (DSM-IV-TR), ed 4. Washington, American Psychiatric Association, 2000.
  2. Goodwin FK, Jamison KR: Manic-Depressive Illness. New York, Oxford University Press, 1990.
  3. Dayer A, Aubry J-M, Roth L, Ducrey S, Bertschy G: A theoretical reappraisal of mixed states: Dysphoria as a third dimension. Bipolar Disord 2000;2:316–324.
  4. Koukopoulos A, Koukopoulos A: Agitated depression as a mixed state and the problem of melancholia. Psychiatr Clin North Am 1999;22:547–564.
  5. Akiskal HS, Pinto O: The evolving bipolar spectrum: Prototypes I, II, III, and IV. Psychiatr Clin North Am 1999;22:517–534.
  6. Benazzi F, Akiskal HS: Delineating bipolar II mixed states in the Ravenna-San Diego collaborative study: The relative prevalence and diagnostic significance of hypomanic features during major depressive episodes. J Affect Disord 2001;67:115–122.
  7. Perugi G, Akiskal HS, Micheli C, Musetti L, Paiano A, Quilici C, Rossi L, Cassano GB: Clinical subtypes of bipolar mixed states: Validating a broader European definition in 143 cases. J Affect Disord 1997;43:169–180.
  8. Perugi G, Akiskal HS, Micheli C, Toni C, Madaro D: Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration. J Affect Disord 2001;67:105–114.
  9. Fava M, Anderson K, Rosenbaum JF: ‘Anger attacks’: Possible variants of panic and major depressive disorders. Am J Psychiatry 1990;147:867–870.
  10. Fava M, Rosenbaum JF, Pava JA, McCarthy MK, Steingard RJ, Bouffides E: Anger attacks in unipolar depression. 1. Clinical correlates and response to fluoxetine treatment. Am J Psychiatry 1993;150:1158–1163.
  11. Fava M, Rosenbaum JF: Anger attacks in patients with depression. J Clin Psychiatry 1999:60(suppl 15):21–24.
  12. Posternak MA, Zimmerman M: Anger and aggression in psychiatric outpatients. J Clin Psychiatry 2002;63:665–672.
  13. Perlis RH, Smoller JW, Racette S, Roffi PA, Rubenstein GEF, Sachs GS, Fava M: A comparison of the prevalence and correlates of anger attacks in bipolar disorder (abstract No 20:9). 155th Annu Meet Am Psychiatr Assoc, Philadelphia, May 18–23, 2002.
  14. Tedlow J, Leslie V, Keefe BR, Alpert J, Nierenberg AA, Rosenbaum JF, Fava M: Axis I and axis II disorder comorbidity in unipolar depression with anger attacks. J Affect Disord 1999;52:217–223.
  15. Baldessarini RJ: Drugs and the treatment of psychiatric disorders. Depression and anxiety, in Hardman JG, Limbird LE, Goodman Gilman A (eds): Goodman & Gilman’s The Pharmacological Basis of Therapeutics, ed 10. New York, McGraw-Hill, 2001, pp 447–483.
  16. Akiskal HS: Classification, diagnosis and boundaries of bipolar disorders: A review; in Maj M, Akiskal HS, Lopez-Ibor JJ, Sartorius N (eds): Bipolar Disorder. Chichester, Wiley, 2002, pp 1–52.
  17. Bowden CL: Pharmacological treatment of bipolar disorder: A review; in Maj M, Akiskal HS, Lopez-Ibor JJ, Sartorius N (eds): Bipolar Disorder. Chichester, Wiley, 2002, pp 191–221.
  18. Moller H-J, Grunze H: Antidepressant treatment of bipolar depression; in Marneros A, Angst J (eds): Bipolar Disorders: 100 Years after Manic-Depressive Insanity. Dordrecht, Kluver Academic Publishers, 2000, pp 387–403.
  19. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L: Antidepressant-induced mania and cycle acceleration: A controversy revisited. Am J Psychiatry 1995;152:1130–1138.
  20. Benazzi F: Antidepressant-associated hypomania in outpatient depression: A 203-case study in private practice. J Affect Disord 1997;46:73–76.
  21. Maris RW: Suicide. Lancet 2002;360:319–326.
  22. Ghaemi SN, Ko JY, Goodwin FK: ‘Cade’s disease’ and beyond: Misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry 2002;47:125–134.
  23. Akiskal HS, Walker P, Puzantian VR, King D, Rosenthal TL, Dranon M: Bipolar outcome in the course of depressive illness: Phenomenologic, familial, and pharmacologic predictors. J Affect Disord 1983;5:115–128.
  24. Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rossler W: Toward a re-definition of subthreshold bipolarity: Epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord 2003;73:133–146.
  25. Benazzi F: Sensitivity and specificity of clinical markers for the diagnosis of bipolar II disorder. Compr Psychiatry 2001;42:461–465.
  26. Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H-J, Hirschfeld R: Re-evaluating the prevalence and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 2000;59(suppl 1):S5–S30.
  27. Baldessarini RJ: A plea for integrity of the bipolar disorder concept. Bipolar Disord 2000;2:3–7.
    External Resources
  28. McMahon FJ, Stine OC, Chase GA, Meyers DA, Simpson SG, DePaulo JR: Influence of clinical subtype, sex, and lineality on age at onset of major affective disorder in a family sample. Am J Psychiatry 1994;151:210–215.
  29. Akiskal HS, Benazzi F: Family history validation of the bipolar nature of depressive mixed states. J Affect Disord 2003;73:113–122.
  30. Angst J: The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998;50:143–151.
    External Resources
  31. Benazzi F: Prevalence of bipolar II disorder in outpatient depression: A 203-case study in private practice. J Affect Disord 1997;43:63–66.
  32. Benazzi F: Bipolar II depression in late life: Prevalence and clinical features in 525 depressed outpatients. J Affect Disord 2001;66:13–18.
  33. Benazzi F, Akiskal HS: Refining the evaluation of bipolar II: Beyond the strict SCID-CV guidelines for hypomania. J Affect Disord 2003;73:33–38.
  34. Hantouche EG, Akiskal HS, Lencrenon S, Allilaire J-F, Sechter D, Azorin J-M, Bourgeois M, Fraud J-P, Chatenet-Duchene L: Systematic clinical methodology for validating bipolar-II disorder: Data in mid-stream from a french national multi-site study (EPIDEP). J Affect Disord 1998;50:163–173.
    External Resources
  35. Cassano GB, Akiskal HS, Savino M, Musetti L, Perugi G, Soriani A: Proposed subtypes of bipolar II and related disorders: With hypomanic episodes (or cyclothymia) and with hyperthymic temperament. J Affect Disord 1992;26:127–140.
  36. Perugi G, Akiskal HS, Lattanzi L, Cecconi D, Mastrocinque C, Patronelli A, Vignoli S, Bemi E: The high prevalence of ‘soft’ bipolar (II) features in atypical depression. Compr Psychiatry 1998;39:63–71.
  37. Angst J: Comorbidity of mood disorders: A longitudinal prospective study. Br J Psychiatry 168;30(suppl):31–37.
  38. Ghaemi SN: Dr. Ghaemi replies. High prevalence of bipolar spectrum disorders, by Benazzi F. J Clin Psychiatry 2001;62:735–736.
  39. Goldberg JF, Kocsis JH: Depression in the course of bipolar disorder; in Goldberg JF, Harrow M (eds): Bipolar Disorders. Clinical course and outcome. Washington, American Psychiatric Press, 1999, pp 129–147.
  40. Ghaemi SN, Boiman EE, Goodwin FK: Diagnosing bipolar disorder and the effect of antidepressants: A naturalistic study. J Clin Psychiatry 2000;61:804–808.
  41. Post RM, Nolen WA, Kupka RW, Denicoff KD, Leverich GS, Keck PE, McElroy SL, Rush AJ, Suppes T, Altshuler LL, Frye MA, Grunze H, Walden J: The Stanley Foundation Bipolar Network. 1. Rationale and methods. Br J Psychiatry 2001;178:S169–S176.
    External Resources
  42. Benazzi F: Borderline personality disorder and bipolar II disorder in private practice depressed outpatients. Compr Psychiatry 2000;41:106–110.
  43. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician version (SCID-CV). Washington, American Psychiatric Press, 1997.
  44. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
  45. Williams JBW, Terman M, Link MJ, Amira L, Rosenthal NE: Hypomania interview guide (including hyperthymia). Current Assessment Version (HIGH-C). Norwood, Clinical Assessment Tools Packet, Center for Environmental Therapeutics, 1994 (rev 2000).
  46. Williams JBW, Terman M, Link MJ, Amira L, Rosenthal NE: Hypomania interview guide (including hyperthymia): Retrospective assessment version (HIGH-R). Depress Anxiety 1999;9:92–100.
  47. Weissman MM, Wickramaratne P, Adams P, Wolk S, Verdeli H, Olfson M: Brief screening for family psychiatric history. The family history screen. Arch Gen Psychiatry 2000;57:675–682.
  48. Dunner DL: Diagnostic revisions for DSM-IV; in Goodnick PL (ed): Mania. Clinical and Research Perspectives. Washington, American Psychiatric Press, 1998, pp 3–10.
  49. Benazzi F: Is 4 days the minimum duration of hypomania in bipolar II disorder? Eur Arch Psychiatry Clin Neurosci 2001;251:32–34.
  50. Akiskal HS: The prevalent clinical spectrum of bipolar disorders: Beyond DSM-IV. J Clin Psychopharmacol 1996;16(suppl 1):4S–14S.
  51. Akiskal HS, Djenderedjian AH, Rosenthal RH, Khani MK: Cyclothymic disorder: Validating criteria for inclusion in the bipolar affective group. Am J Psychiatry 1977;134:1227–1233.
  52. Coryell W, Endicott J, Maser JD, Keller MB, Leon AC, Akiskal HS: Long-term stability of polarity distinctions in the affective disorders. Am J Psychiatry 1995;152:385–390.
  53. Mitchell PB, Wilhelm K, Parker G, Austin MP, Rutgers P, Malhi GS: The clinical features of bipolar depression: A comparison with matched major depressive disorder patients. J Clin Psychiatry 2001;62:212–216.
  54. Coryell W: Bipolar II disorder: The importance of hypomania; in Goldberg JF, Harrow M (eds): Bipolar Disorders. Clinical course and outcome. Washington, American Psychiatric Press, 1999, pp 219–236.
  55. Robins E, Guze SB: Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia. Am J Psychiatry 1970;126:983–987.
  56. Kendler KS: The nosologic validity of paranoia (simple delusional disorder). Arch Gen Psychiatry 1980;37:699–706.
  57. Kendler KS: Toward a scientific psychiatric nosology. Strengths and limitations. Arch Gen Psychiatry 1990;47:969–973.
  58. Joffe RT, Young LT, MacQeen GM: A two-illness model of bipolar disorder. Bipolar Disord 1999;1:25–30.
  59. Baldessarini RJ, Ghaemi NS, Viguera AC: Tolerance in antidepressant treatment. Psychother Psychosom 2002;71:177–179.
  60. Schmidt ME, Fava M, Zhang S, Gonzales J, Raute NJ, Judge R: Treatment approaches to major depressive disorder relapse. 1. Dose increase. Psychother Psychosom 2002;71:190–194.
  61. Fava M, Schmidt ME, Zhang S, Gonzales J, Raute NJ, Judge R: Treatment approaches to major depressive disorder relapse. 2. Reinitiation of antidepressant treatment. Psychother Psychosom 2002;71:195–199.
  62. Akiskal HS, Mallya G: Criteria for the ‘soft’ bipolar spectrum: Treatment implications. Psychopharmacol Bull 1987;23:68–73.
  63. Dunner DL, Tay KL: Diagnostic reliability of the history of hypomania in bipolar II patients and patients with major depression. Compr Psychiatry 1993;34:303–307.
  64. Brugha TS, Jenkins R, Taub N, Meltzer H, Bebbington PE: A general population comparison of the Composite International Diagnostic Interview (CIDI) and the Schedules for Clinical Assessment in Neuropsychiatry (SCAN). Psychol Med 2001;31:1001–1013.
  65. Simpson SG, McMahon FJ, McInnis MG, MacKinnon DF, Edwin D, Folstein SE, DePaulo JR: Diagnostic reliability of bipolar II diagnosis. Arch Gen Psychiatry 2002;59:736–740.
  66. American Psychiatric Association: Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002;159(4 Suppl):1–50.
  67. Kraepelin E: Manic-Depressive Insanity and Paranoia. Edinburgh, Livingstone, 1921.
  68. Kupfer DJ, Frank E, Grochocinski VJ, Cluss PA, Kouck PR, Stapf DA: Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J Clin Psychiatry 2002;63:120–125.
  69. Suppes T, Leverich GS, Keck PE, Nolen WA, Denicoff KD, Altshuler LL, McElroy SL, Rush AJ, Kupka RW, Frye MA, Bickel M, Post RM: The Stanley Foundation Bipolar Treatment Outcome Network. 2. Demographics and illness characteristics of the first 261 patients. J Affect Disord 2001;67:45–59.
  70. Kupfer DJ, Carpenter LL, Frank E: Possible role of antidepressants in precipitating mania and hypomania in recurrent depression. Am J Psychiatry 1988;145:804–808.
  71. Amsterdam JD, Garcia-Espana F, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Schweizer E, Beasley C: Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. J Clin Psychopharmacol 1998;18:435–440.
  72. Amsterdam J: Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode. J Clin Psychopharmacol 1998;18:414–417.

Article / Publication Details

First-Page Preview
Abstract of Regular Article

Published online: October 09, 2003
Issue release date: November – December

Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 2

ISSN: 0033-3190 (Print)
eISSN: 1423-0348 (Online)

For additional information: https://www.karger.com/PPS


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.